Novo Nordisk completes DKK 3.8 billion share buyback as part of a larger DKK 15 billion program

Novo Nordisk concluded a share repurchase program from February to May 2026, buying back 14.76 million B shares worth DKK 3.8 billion at an average price of DKK 257.47 per share. This is part of a larger 12-month plan to repurchase shares up to DKK 15 billion starting February 2026. The company now holds about 0.7% of its share capital as treasury shares. This buyback reflects Novo Nordisk's strategy to return value to shareholders while managing its capital structure.